REPLAY HOLDINGS
Summary
Replay is a genome writing company, which aims to define the future of genomic medicine through reprogramming biology by writing and delivering big DNA.
Deals Overview
Total Deals1
Valued Deals1
Total Value£46M
Avg. Deal Size£46M
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
